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Nos últimos anos, terapias à base de anticorpos mono e policlonais têm 
atraído muita atenção por parte da indústria farmacêutica levando a um 
aumento da investigação neste campo. A imunoglobulina G (IgG), um dos 
anticorpos já aprovados pela Food and Drug Administration (FDA) é uma 
das imunoglobulinas mais abundantes nos mamíferos, cuja obtenção requer 
o uso de técnicas invasivas. Como alternativa, e devido às semelhanças 
estruturais com a IgG, surge o uso da imunoglobulina Y (IgY) que se 
encontra presente na gema de ovo de galinha. Além disso, as quantidades 
de IgY presente na gema do ovo são bastante altas (100-150 mg/ovo) 
quando comparadas com a quantidade de IgG no soro (200mg/40mL de 
sangue). Contudo, o isolamento da IgY a partir da gema de ovo é bastante 
dispendioso e moroso, uma vez que requer o uso de processos com várias 
etapas. Tendo em conta estas desvantagens torna-se indispensável o 
desenvolvimento de um método mais económico e mais biocompatível. Os 
sistemas micelares de duas fases aquosas, um tipo específico de sistemas 
de duas fases aquosas que recorrem ao uso de surfactantes, surge como 
alternativa para a extração, purificação e/ou concentração de 
(bio)moléculas. Adicionalmente, o uso de líquidos iónicos (LIs) como co-
surfactantes pode modificar as propriedades do surfactante e dessa forma 
conduzir a mudanças na extração das (bio)moléculas. Neste sentido, o 
objetivo deste trabalho é o desenvolvimento de um novo método para a 
extração, purificação e concentração da IgY através do uso de sistemas 
micelares de duas fases aquosas convencionais e mistos com LIs 
pertencentes à família dos imidazólios e fosfónios a atuar como co-
surfactantes. Para tal, foram otimizados parâmetros como a concentração 
de surfactante e da fração de proteínas solúveis em água, a ausência e 
presença de (LIs) bem como o efeito da sua concentração e estrutura 
química. Após toda a otimização, os melhores resultados foram obtidos com 
o sistema convencional e sistema misto com [C16mim]Cl, onde se obtiveram 
purificações de 51.2 % e 64.5% e rendimentos de 100% e 
74.7%respetivamente.    
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Abstract In the past few years, therapies based on mono- and polyclonal 
antibodies have attracted attention from pharmaceutical industries 
leading to a drastic research increment in this field. Immunoglobulin G 
(IgG), one of the antibodies already approved by Food and Drug 
Administration (FDA), is the most abundant mammalian immunoglobulin, 
whose acquisition requires the use of invasive techniques. As an 
alternative to the use of mammalian antibodies, Immunoglobulin Y (IgY) 
from hens’ egg yolk emerges due to its structural similarity to IgG. 
Furthermore, the IgY amount present in egg’s yolk can be quite high (100-
150 mg/egg) when compared with the IgG amount in the blood serum 
(200 mg/40 mL of blood). However, IgY isolation from the egg’s yolk is 
quite expensive and time consuming, since it requires multistep 
processes. Taking these disadvantages into account, the development of 
a cheaper and more biocompatible technique for IgY extraction and 
purification becomes mandatory. Aqueous micellar two-phase systems 
(AMTPS) are a special type of aqueous two-phase systems that comprise 
micellar solutions of surfactants for (bio)molecules extraction, purification 
and/or concentration. Additionally, the use of ionic liquids (ILs) as co-
surfactants can modify the surfactant properties, leading to changes in 
the phase separation as well as in the (bio)molecules fractionation. In this 
sense, this work aims at the development of a new extraction, purification 
and concentration technique for IgY from egg’s yolk using both 
conventional and mixed AMTPS with tensioactive ILs belonging to two 
distinct families, namely imidazolium and phosphonium, acting as co-
surfactants. Thus, parameters like the surfactant and the water-soluble 
proteins fraction (WSPF) concentration, the presence/absence of IL as 
well as the effect of its concentration and structural features were 
optimized. After the optimization procedure, the best results were 
obtained with the conventional system and mixed AMTPS with 
[C16mim]Cl, were a purification of 51.2 % and 64.5 %  and yields of 100% 
and 74.7%, respectively, were obtained. 
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1. General Introduction 
1.1. Scope and Objectives 
In the past few years, therapies based on mono- and polyclonal antibodies have attracted 
much attention from pharmaceutical industries leading to a drastic research increment in 
this field. However, any new compound within the medical field must undergo several 
steps and clinical trials in order to avoid human casualties, and it starts with the Food and 
Drug Administration (FDA) approval. So far, several antibody-based therapies have been 
developed in order to treat different disorders and/or diseases, such as cancer [3,4], 
transplant rejection [5], auto-immune disorders [6], asthma [7] and infectious diseases 
[8]. Immunoglobulin G (IgG), one of the antibodies already approved by FDA [9], is the 
most abundant mammalian immunoglobulin and it is responsible for the transition 
between innate and cell mediated immune responses [2]. However, to acquire IgG from 
mammal serum, the use of invasive techniques such as animal bleeding is required, 
leading sometimes to the animal’s death. As an alternative, monoclonal IgG antibody can 
also be obtained through mammalian culture cells; however, this approach involves high 
production costs since it needs the acquisition of transfected cells, culture media and 
laborious procedures [10]. As a substitute for the use of mammalian antibodies, 
immunoglobulin Y (IgY) from hens’ egg yolk plays a promising role. The IgY molecule 
has a similar structure to IgG and does not require animals suffering, since it is obtained 
from the egg yolk. Furthermore, the quantities present in the egg yolk can be quite high 
(100-150 mg/egg) when compared with the amount of IgG in blood serum (200 mg/40 
mL of blood) [1]. IgY also displays phylogenetic distance from mammals, and thus, 
allowing the production of antibodies against highly conserved mammalian proteins. 
Moreover, the use of hens as the host for IgY production has lower costs when compared 
to the use of mammals. The recommendations of European Center for Validation of 
Alternative Methods specifies that, considering animal welfare reasons, IgY acquired 
from egg’s yolk should be used instead of mammalian IgG [11]. 
Currently, the IgY isolation from egg’s yolk is quite expensive and time consuming since 
it requires multistep processes [12], usually carried out through liquid-liquid extraction 
using organic solvents, which are hazardous to the environment and non-biocompatible 
when dealing with proteins [13,14]. Other methods such as precipitation [15], 
chromatography with the use of affinity ligands [16] or filtration [17] have also been 
attempted, but are difficult to be used in an industrial scale. In this sense, it is mandatory 
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the development of cheaper and more biocompatible techniques for IgY extraction and 
purification. For this purpose, the use of aqueous two-phase systems (ATPS), a particular 
type of liquid-liquid extraction, is a promising alternative. ATPS have already been 
applied in the extraction of several (bio)molecules, such as proteins [18,19], DNA 
plasmids [20], antibiotics [21], dyes [22], hormones [23] and cells [24] without the 
significant denaturation, degradation or loss of biological activity. Aqueous micellar two-
phase systems (AMTPS) are a special type of ATPS that comprise micellar solutions of 
surfactants for (bio)molecules extraction, purification and/or concentration [25–28]. 
Furthermore, surfactant micellar solutions allow the extraction of (bio)molecules with 
distinct polarities since they offer, simultaneously, both hydrophobic and hydrophilic 
environments [26]. Changes on surfactant type, temperature and pH can additionally 
improve the (bio)molecules separation and purification [29–33]. Additionally, the use of 
ionic liquids (ILs) as co-surfactants can modify the polymer or surfactant properties, 
which leads to changes in phase separation and (bio)molecules extraction (yields and 
selectivity) [34,35]. In this sense, this work aims at the development of a new extraction, 
purification and concentration technique for IgY using both conventional and novel 
AMTPS. This study will be accomplished by using the non-ionic surfactant Triton X-114 
and tensioactive ILs as co-surfactants, those belonging to two distinct families, the 
imidazolium- and phosphonium-based ones.  
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1.2 State of the art 
1.2.1. Immunoglobulins structure  
Antibodies, also named immunoglobulins (Ig), are glycoproteins secreted by specialized 
plasma cells, namely the B lymphocytes. Structurally, immunoglobulins are composed of 
four polypeptides: two heavy chains (H) and two light chains (L), as presented in Figure 
1. Those chains have two main regions: the N-terminal region also known as the variable 
(V) region and a C-terminal or constant (C) region, connected by disulfide bonds. 
Immunoglobulins can suffer proteolytic digestion and originate two separated fragments, 
the Fab and the Fc, connected by a hinge region rich in proline, threonine, and serine. The 
Fc fragment is responsible for the effector properties, such as natural killer cells 
activation, classical complement pathway activation and phagocytosis. The Fab fragment 
is the one containing the antigen-binding domains [2].  
 
Figure 1: General immunoglobulin structure. Adapted from [2]. 
Antibody functions are dependent on the interactions between antibodies and antigens, 
though they are conditioned by the complexity and number of antigen’s epitopes present 
[2]. One antigen can be recognized by a large number of lymphocytes T through antigen-
presenting cells, such as macrophages, that will consequently activate different plasma 
cells, thus resulting in a polyclonal response by polyclonal antibodies [2]. If only one B 
lymphocyte is activated and proliferates, the response will be through monoclonal 
antibodies with a single specificity. Rabbits, sheep and goats are usually used for the 
polyclonal antibodies production due to their size. From this group, the most used animal 
is the rabbit since their maintenance is less expensive. On the other hand, for monoclonal 
antibodies, mice are the most used species owing to their small size [36]. The mammalian 
immune system has several clonal lymphocytes populations that exhibit antigen-receptor 
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specificity. Due to this lymphocyte diversity, the immune system will respond to 
numerous antigens, corresponding to foreign proteins, carbohydrates, peptides, bacterial 
and viral components [11]. In this sense, depending on the antigen, different types of 
immunoglobulins will be produced and will circulate in the blood stream. Mammals 
produce five different types of immunoglobulins: IgG, IgM, IgA, IgD, and IgE; whereas 
for avian species only three types of immunoglobulins are found: IgY, IgM, and IgA. The 
last two immunoglobulins are identical to the mammalian correspondent ones and the IgY 
is similar to the mammalian IgG; nonetheless, with some differences which are presented 
in Table 1 [36]. When considering the host for antibodies production, it is also important 
to take into account the main goal of the European Center for Validation and Alternative 
Methods, which requires the reduction or replacement of laboratory animals. In the case 
of IgG, non-mammalian species can be used for antibodies production without the use of 
invasive techniques, namely by the use of cells cultures. As aforementioned, the use of 
hens as an antibody host not only eliminates the use of invasive techniques but also offers 
a phylogenetic divergence [11]. Due to this phylogenetic distance between birds and 
mammals, IgY leads to an enhanced immune response in mammals when compared with 
IgG. 
Table 1: Differences between the mammalian IgG and IgY. Adapted from [1]. 
 
Rabbits (IgG) Hens (IgY) 
Antibody source Blood serum Egg’s yolk 
Type of antibody Polyclonal Polyclonal 
Quantities 200 mg/40 mL blood 100-150 mg/egg 
Protein A/G binding Yes No 
Interaction with mammalian Ig G Yes No 
Activation of complement Yes No 
Interaction with rheumatoid factor Yes No 
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1.2.2. Immunoglobulin Y  
The hen immune system is different from the mammalian one; in mammals, the 
transference of the antibodies occurs after birth [2], whilst in the avian immune system, 
antibodies are transferred to the egg in order to offer the chick an immune protection [1]. 
The egg is composed of the shell, albumen and yolk, and the yolk constituents are 
synthesized in the hens liver and then transferred to the blood, where they are carried to 
be later transferred to the egg [1]. Amongst distinct avian antibodies, IgY is the most 
prominent one, presenting concentrations ranging from 5 to 15 mg/mL, while IgA and 
IgM concentrations are 0.3-0.5 mg/mL and 1-3 mg/mL, respectively [37]. Although egg 
yolk is a highly complex matrix, it can be separated by high-speed centrifugation into 
granules and plasma. The granules are composed of 70% of α- and β- lipovitellins, 60% 
phosphovitin and 12% of low-density lipoproteins. On the other hand, the plasma is 
composed of 33% of low-density lipoprotein fraction and 5% of water soluble protein 
fraction (WSPF) [1]. 
IgY and IgG, Figure 2, are similar, only with some differences in their structure:  IgG 
presents 3 C regions in its H chain, whereas IgY holds 4 C regions, which is then 
translated in a larger molecular weight (180 kDa) when compared with IgG (150 kDa). 
The addition of an extra C region also leads to the loss of flexibility in IgY since it loses 
the hinge region [38]. In relation to pH stability, IgY activity suffers a decline at pH 3.5, 
however, at pH 3, there is a complete loss of the IgY activity [39]. On the other hand, IgG 
does not suffer any changes in its activity for values above pH 2 [39]. Furthermore, in 
relation to temperature, IgY suffers a loss of activity at 70ºC and IgG at 75-80ºC [39].  
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Figure 2: Structure of IgG (a) and IgY (b) representation of H and L chains, hinge region and C and V 
domains. Adapted from [1]. 
 
Despite the clear advantages of IgY, one of the biggest drawbacks of the IgY large-scale 
application is its problematic isolation from the complex egg yolk matrix. Usually, the 
methods employed are divided into two distinct steps: the first one involves the recovery 
of the WSPF, which is rich in immunoglobulins, among other water-soluble proteins [12]. 
In this sense, precipitation, dilution and freeze and thaw cycles are usually applied to 
precipitate the yolk’s granules and to acquire the WSPF as the supernatant [12]. Once the 
WSPF is attained, it is necessary to eliminate the other contaminant proteins in order to 
collect the pure IgY. Throughout the years, different methods have been investigated to 
this end [15–17,40,41]. Hatta and co-workers [40] applied natural gums for the 
precipitation of lipoproteins from egg yolk. For this, a solution with 0.15% of λ-
carrageenan was added to the diluted egg yolk and then centrifuged; afterwards, the 
supernatant was filtered and submitted to three chromatographic cycles with sodium 
sulphate obtaining IgY at 98% of purity and with a yield of 73%. Kim and Nakai [17] 
implemented ultrafiltration for IgY purification using diverse membranes with different 
cut-off values and achieved purification values between 74-99% and yields from 72 to 
85%. Moreover, Verodilva and co-workers [16] tested a chromatography column with an 
affinity ligand for IgY purification and attained a purity around 90% and an yield of 10 
mg of IgY/mL of resin. The IgY purification was also pursued using water dilution and 
salt induced precipitation steps [42]. Zhen and co-workers [42] diluted the egg yolk in 
water followed by the proteins precipitation using ammonium sulphate and sodium 
sulphate, followed by an ultrafiltration step using a 100 kDa cut-off membrane. The level 
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of purity accessed was around 86% after several purification steps [42]. Later on, in 2010, 
Deignan and co-workers [15] compared different purification methods. For the lipidic 
fraction removal from the egg yolk, the following approaches were investigated: (i) freeze 
and thaw cycles at neutral pH, followed by precipitation with 3.5% of polyethylene glycol 
(PEG) of the diluted egg yolk in a phosphate buffer; (ii) precipitation with dextran 
sulphate and calcium chloride, and also (iii) precipitation with phosphotungstic acid and 
magnesium chloride of the diluted egg yolk in a Tris-buffered saline (TBS) solution. All 
these methods were followed by centrifugation. After the lipids removal, the IgY 
precipitation was carried out by precipitation with sodium sulphate at pH 6, at two 
different concentrations, and at 30ºC, followed by centrifugation and dialysis against TBS 
for the removal of sodium sulphate. The same procedure was also attempted with 
ammonium sulphate. The precipitation of IgY was also carried out with a solution of 12% 
of PEG with a molecular weight of 8000 followed by centrifugation and dialysis. The 
purification results for IgY after the lipids removal were around 60% [15]. More recently, 
Priyanka and co-workers [41] used a PEG 1500/potassium phosphate ATPS and a three-
phase partitioning system with t-butanol and ammonium sulphate for the extraction and 
purification of IgY. The results obtained showed higher yields for the ATPS (9.0 mg/mL) 
than for the three-phase partitioning process (6.0 mg/mL). Considering that these methods 
usually involve multistep approaches and the use of organic solvents (hazardous for the 
environment and proteins), it becomes urgent the development of an effective, cheaper 
and more biocompatible method for the IgY purification. 
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1.2.3. Extraction and purification processes using aqueous (micellar) two-phase 
systems 
Advances in biotechnology have created a number of opportunities for (bio)molecules 
large-scale production and promoted the development of more efficient, cheaper and 
sustainable techniques. The use of liquid-liquid extraction systems offers the possibility 
of combining several steps in only one process, namely the compound’s extraction and 
purification, and involves the transference of components from one phase to the other 
when immiscible or partially soluble liquid phases are in equilibrium [43]. ATPS 
comprise liquid-liquid extraction principles and are formed when two different aqueous 
solutions are mixed above a certain concentration of different components, namely 
polymer-polymer [44], polymer-salt [19,20,45], IL-salt [46,47], and more recently, 
polymer-surfactant [48] combinations. These different types of ATPS have already been 
applied for the recovery and purification of several (bio)molecules, such as proteins 
[18,19,45,49–51], plasmid DNA [20], antibiotics [21], dyes [22], hormones [23] and cells 
[24], without the denaturation, degradation or loss of biological activity of the 
compounds. Human antibodies are another type of biomolecules already extracted using 
ATPS by combining PEG 3350/dextran [44] and PEG 6000/NaCl [45] pairs. However, 
to increase the purity levels, additional steps requiring the use of affinity ligands are 
usually employed [44]. ATPS have other advantages, namely their potential for scale-up 
and capacity to purify and concentrate various (bio)molecules in a single-step [45]. The 
(bio)molecules interaction with the system components can be promoted through 
hydrogen bonding, ionic and hydrophobic interactions, and thus the net effect is different 
in both phases. This normally allows the preferential migration/partition of the target 
(bio)molecules to one of the phases [52]. Moreover, the (bio)molecules migration is also 
influenced by their intrinsic properties, for instance, size, electrochemical properties, 
surface hydrophobicity/hydrophilicity, conformational characteristics, and extrinsic 
properties such as the ionic strength, molecular weight, concentration of the phase 
forming components, pH, and temperature [45,50,53]. Nonetheless, conventional ATPS 
present some limitations since several of the polymers applied have high viscosities, a 
limited range of polarities and some can also be quite expensive making it difficult to be 
employed at an industrial level [54]. In order to overcome these difficulties, Rogers and 
co-workers [55] reported the possibility of using ILs in the ATPS formation, thus 
revolutionizing the process for (bio)molecules extraction [23,47,56–61]. 
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ILs are salts composed of a large organic cation and a small organic or inorganic anion, 
conferring them an asymmetrical ionic structure and higher temperatures of 
crystallization. As salts, ILs present a negligible vapor pressure and non-flammability, 
being also characterized by their high chemical and thermal stabilities. However, one of 
the most interesting properties of ILs is the possibility to combine several anions and 
cations, which gives them the so called “designer solvents” character [62]. Depending on 
their cation, ILs belonging to phosphonium, ammonium and cholinium families are 
usually more compatible with (bio)molecules, allowing them to be more adequate for 
their extraction [47,63]. Compared to imidazolium-based ILs, the phosphonium-based 
fluids have a greater ability to form ATPS in the presence of the same anions [47,60]. 
This behavior can be related to the different affinities of both classes of ILs for water 
[47,60]. (Bio)molecules extraction using ILs as phase-forming components of ATPS is 
also dependent on the use of different salts, temperatures and pH values [56]. In some 
cases, lower pH values improve the purification results since the proteins partitioning can 
be manipulated by changes in their isoelectric points [61]. When applied in ATPS, ILs 
allow the broadening of polarities and affinities [62]. In addition to the use of ILs to form 
IL-salt and IL-polymer ATPS, the use of ILs as co-adjuvants (in low quantities) alongside 
other polymers can improve the (bio)molecules separation, since it causes alterations in 
the aqueous phase polarities allowing the manipulation of the (bio)molecules extraction 
[35,59]. Studies have shown that the addition of 5 wt% of [Cnmim]Cl-based ILs increase 
the two-phase region and the (bio)molecules extraction results following the increment 
of their hydrophobic nature ([C2mim]Cl > [C4mim]Cl >[C6mimCl]) [35]. However, even 
with the incorporation of ILs into ATPS, these systems still present some drawbacks, for 
instance the increased economic impact derived from the use of ILs (e.g., in the previous 
mentioned study [35] 5 wt% of IL are required in each ATPS). In order to overcome this 
problem, a step of back extraction is normally added to recover the IL [47]. Furthermore, 
in some cases the (bio)molecule of interest is extracted in the IL rich-phase, which could 
lead to biocompatibility issues since the IL can interact negatively with the (bio)molecule. 
In this sense, AMTPS, a specific type of ATPS, appear as an attractive alternative to these 
systems since they are only composed of surfactants and water (or a buffer if the control 
of the system pH is required) as the system components [25–28,64], thus reducing the 
amount of solvents required for the system preparation. Even when combined with ILs as 
co-surfactants, significantly lower amounts are employed, ranging from 0.3 to 0.5 wt% 
[34,65]. Besides, AMTPS are capable of extracting, purifying and even concentrate 
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several biomolecules, specially proteins, without losses on their activity and native 
conformation, which is commonly justified by the lack of interactions between the system 
components and the proteins [66]. In particular, the (bio)molecules extraction, separation 
and purification is mainly dependent on the surfactants micellar aggregation capacity 
[66]. Surfactants are amphiphilic molecules formed by a hydrophilic (polar) moiety, 
known as the head, and a hydrophobic (nonpolar) moiety established as the tail. When 
dissolved in water above its critical micellar concentration (CMC), surfactants aggregate 
in a noncovalent way and form micelles in order to minimize the water contact with the 
hydrophobic moiety [67,68]. Moreover, these systems are dependent of specific 
temperatures and surfactant concentrations. Usually, the experimental procedure applied 
to determine the binodal curves is based on the method described by Huang [69]. In this 
method, a solution with a certain concentration of surfactant is set up in a controlled 
temperature bath and slowly heated until the solution becomes turbid and suffers phase 
separation. This specific temperature known as the cloud point or Tcloud, when plotted 
with the different surfactant concentrations under study, describe the binodal curve 
obtained for this specific system, similar to that presented in Figure 3. Under an 
appropriated temperature and surfactant concentration, the system displays one micelle-
poor phase and one micelle-rich phase that usually corresponds to the top and bottom 
phases, respectively. In the particular case of AMTPS of non-ionic surfactants from the 
poly(oxyethylene) alkyl ether (POEAEs) family, the temperature at which the AMTPS 
suffers separation depends on the balance between the alkyl chain length and the length 
of the poly(oxyethylene) chain of the surfactant. For POEAEs with the same alkyl length, 
the Tcloud increases with the poly(oxyethylene) alkyl chain length increment [30].  
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Figure 3: Binodal curve for Triton X-114. At temperatures below the Tcloud, the AMTPS only has one 
homogeneous phase and above the Tcloud, the homogeneous mixture is separated into two phases: one 
micelle-poor phase and one micelle-rich phase. Adapted from [34]. 
The Tcloud can be modified by the addition of inorganic salts: if the salt has the ability to 
promote the salting-out, such as chloride- or sulphate-based salts, the system Tcloud is 
lower; on the other hand, if the salt induces the salting-in, e.g. nitrate- or thiocyanate-
based salts, the system Tcloud is higher [70,71]. The salt effect on the system Tcloud is 
related with the hydration of the surfactant poly(oxyethylene) chains. In this sense, 
salting-in inducing salts have weaker electric fields and a smaller hydration shell, which 
leads to an increment on the concentration of free water molecules that form hydrogen 
bonds with the poly(oxyethylene) chains. On the other hand, salting-out salts possess high 
electric fields and bind strongly with the water molecules, thus competing with the 
poly(oxyethylene) chains for the water molecules, which leads to a dehydration of the 
chains and consequent Tcloud reduction [71]. Moreover, the (bio)molecules extraction is 
dependent on their properties, so hydrophobic and hydrophilic proteins should migrate to 
the micelle-rich and micelle-poor phases, respectively, as firstly demonstrated by Bordier 
[26] and more recently by Vicente et al. [34]. The (bio)molecules separation/purification 
is also dependent on repulsive and steric interactions as well as on the molecules size. If 
the (bio)molecule molecular weight is higher than the micelle size, then the molecule 
partitions preferably towards the micelle-poor phase due to the micelles exclusion volume 
effect [25,27,66]. The exact mechanism for this separation phenomenon is not completely 
understood but it is possibly associated with competitions between entropic and enthalpic 
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factors [29]. It should be noted that the phase separation is reversible and can be 
associated with temperature variations, since below the Tcloud, the surfactant micelles are 
solubilized in water due to hydrogen bonds promoted between the solvent and the 
poly(oxyethylene) chains. With the temperature raising, the hydrogen bonds are reduced, 
and the aggregation phenomenon starts [30].  
In proteins separation/purification, the most common surfactant reported is Triton X-114 
[72] due to its relatively low Tcloud, around 22ºC [28,71]. However, other surfactants could 
also be applied in the proteins purification, namely alkylglucosides [31], zwitterionic 
surfactants [32], triblock copolymer surfactants [29,73], and mixtures of cationic and 
anionic surfactants [33]. The mixture of different surfactants allows an adequate 
manipulation of different factors, namely variations on CMC, micelle shape [29,74], 
(bio)molecules solvation and extraction abilities [33],among others. Nonetheless, when 
ionic surfactants are employed, it should be taken into account that, in order to avoid 
protein denaturation, the amount of ionic surfactant in the system should only be high 
enough to induce changes in the protein partitioning behavior, but without compromise 
the proteins conformational structure of activity [29]. Changes in pH also change the 
(bio)molecules extraction, and those alterations could be related with modifications on 
the electrical charge of the (bio)molecule, which can affect the repulsive and/or attractive 
interactions between the (bio)molecules and the surfactant [75], consequently promoting 
a distinct migration behavior.  
Some ILs were found to exhibit surface active properties similar to surfactants, having 
the ability to form micelles as demonstrated by several studies of small angle neutron 
scattering analysis (SANS), surface tension, conductivity [76], and steady-state 
fluorescence measurements [77]. The ILs CMC is dependent on the number of methylene 
(-CH2-) groups present in the aliphatic moiety, and for which ILs with more methylene 
groups require a lower concentration in order to form micelles [78]. Different anions also 
influence the ILs’ CMC even if the surface-active feature arises from the IL cation: the 
larger the anion, the lower the CMC is, since ions that are less hydrated will be more 
easily adsorbed and suffer lesser electrostatic repulsions, leading to an easier aggregation 
[79]. Furthermore, temperature variations lead to changes in CMC values of ILs in 
aqueous solutions since it also reduces the hydration of the IL anion, favoring the IL 
aggregation [80]. Considering the IL ability to self-aggregate, the addition of IL to other 
surfactants can originate mixed micelles [81–83] with different diameters, CMC, and 
surface charge [84]. The pioneer work of Vicente et al. [34] demonstrated the possibility 
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of using Triton X-114 and ILs as co-surfactants for the selective extraction of target 
(bio)molecules, namely cytochrome c and rhodamine 6G. It was demonstrated that the 
use of different ILs influences the Tcloud of the AMTPS: imidazolium-based ILs require 
superior temperatures to create the AMTPS due to their higher hydrophilic nature; on the 
other hand, phosphonium- and ammonium-based ILs need lower temperatures to promote 
the same phase separation owing to its more hydrophobic character [34]. Variations on 
the ILs concentration can also induce changes in the system Tcloud by pronouncing the 
previous effects [34]. Additionally, these systems were proven to enhance the extraction 
performance and to be very selective with a selectivity improvement from 925.25 of 
conventional AMTPS to 3418.89 for a mixed AMTPS with ILs acting as co-surfactants 
[34]. The enhanced extraction was also explained by an increment in the surfactant 
concentration, which increases the system entropy, thus leading to micelles fusion that 
results in micelles with larger diameters and better separation results [66]. This selectivity 
can be further explained by hydrophobic, electrostatic and excluded-volume 
phenomenon’s with hydrophilic proteins presenting an higher affinity to the micelle-poor 
phase but also with smaller (bio)molecules migrating to the micelle-rich phase [34]. 
Taking into account the nature and characteristics of AMTPS employing ILs as co-
surfactants, it seems that they may be an attractive alternative for IgY purification.  
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2. Experimental Section  
2.1. Materials and reagents 
The nonionic surfactant Triton X-114 used in the AMTPS preparation was supplied by 
Sigma Aldrich/Acros Organics and the McIlvaine buffer components, particularly citric 
acid (C6H8O7, purity = 99.5%) and disodium phosphate (Na2HPO4, purity = 99%) were 
acquired from Panreac and Merck, respectively. For the mixed AMTPS preparation using 
ILs as co-surfactants, the ILs used, namely 1-decyl-3-methylimidazolium chloride 
[C10mim]Cl (purity > 98 wt%), 1-dodecyl-3-methylimidazolium chloride [C12mim]Cl 
(purity > 98 wt%) and 1-methyl-3-tetradecylimidazolium chloride [C14mim]Cl (purity > 
98 wt%) were acquired from Iolitec (Ionic Liquid Technologies, Heilbronn, Germany). 
All the phosphonium-based ILs, namely trihexyltetradecylphosphonium chloride, 
[P6,6,6,14]Cl (purity > 93 wt%); trihexyltetradecylphosphonium bromide, [P6,6,6,14]Br 
(purity > 96.0 wt%); trihexyltetradecylphosphonium decanoate, [P6,6,6,14]Dec (purity > 97 
wt%); and trihexyltetradecylphosphonium bis (2,4,4-trimethylpentyl)phosphinate 
[P6,6,6,14]TMPP (purity > 93.0 wt%) were kindly offered by Cytec. The components of the 
phosphate buffer used as the mobile phase for Size Exclusion High Performance Liquid 
Chromatography (SE-HPLC) analysis, namely Na2HPO4.7H2O, NaH2HPO4 and NaCl 
were attained at Panreac with purities above 98%. The staining solution Coomssie Blue 
(G-250) was purchase from AMRESCO, whereas the destainning solution components, 
methanol and acetic acid, were supplied by Fisherchem. The components of the loading 
and running buffer for the electrophoresis, bromophenol blue, were provided by Merck, 
Tris base by Pronolab, glycine with 99% of purity by Acros, glycerol by Sigma-Aldrich 
and dithiothreitol (DTT) by Acros Organics. The gel of electrophoresis used in the SDS-
PAGE analysis was purchased from Amersham.  
 
2.2. Methods 
2.2.1. Preparation of the Water Soluble Protein Fraction 
In order to acquire the IgY-rich WSPF from chicken’s egg yolk, it was followed the 
standard experimental protocol reported by Liu et al. [85].  
 
2.2.2. Preparation of the AMTPS for the IgY extraction and purification 
For the optimization studies of the surfactant and WSPF concentrations, several 
conventional AMTPS were prepared. Firstly, the surfactant concentration study was 
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carried out by weighting all the systems components into a falcon tube: 1, 5, 10, 15 or 20 
wt % of Triton X-114 + 10 wt% of WSPF + McIlvaine buffer pH 6.0 (184.25 mL of 
C6H8O7.H2O at 0.1M + 315.75 mL of Na2HPO4 at 0.2M) to complete a final volume of 
10 mL. Then, the AMTPS were homogenized at 4ºC in a freezer for at least 2 hours, using 
a rotor apparatus Stuart SB3 at 35 rpm. Afterwards, the systems were left at 35ºC in a 
Venticell incubator overnight in order to reach the thermodynamic equilibrium and to 
guarantee the complete phase separation. The result was a micelle-rich phase (bottom 
phase) and a micelle-poor phase (top phase). These were carefully separated and their 
volumes and weights collected. After the proper optimization of the surfactant 
concentration, this procedure was repeated for the WSPF concentration study using 20 wt 
% of Triton X-114 + 10, 17.5 or 25 wt % of WSPF + McIlvaine buffer (pH 6.0) to 
complete the final volume of 10 mL. Finally, the complete optimized system was carried 
out to study the effect of the IL addition as co-surfactant (Figure 4) to the AMTPS: 20 
wt % of Triton X-114 + 0.3 or 0.5 wt % of IL + 25 wt % of WSPF + McIlvaine buffer pH 
6.0 to complete the final volume of 10 mL. It should be stressed that all studies were 
performed in triplicate and the respective average and standard deviations were 
determined. Moreover, when working with mixed AMTPS, an interval of temperatures 
(35 - 50ºC) was studied due to the Tcloud variations imposed by the ILs addition. For ILs 
belonging to the imidazolium family, the phase separation occurs at 37ºC and higher 
temperatures due to its higher hydrophobicity. Regarding the phosphonium-based ILs, 
the tests of purification of IgY were carried at 35ºC and 37ºC. 
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Figure 4: Chemical structure of the anions and cations that composed the imidazolium-based and 
phosphonium-based ILs applied to the AMTPS. 
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2.2.3. AMTPS preparation for the consecutive IgY purification cycles 
After the optimization of the best ILs for the purification of IgY, new consecutive 
extraction cycles were applied to the resulting top-phase of the mixed AMTPS. In the 
case of the AMTPS with 0.3 wt% of [C14mim]Cl, the system top-phase was applied in 
consecutive extraction cycles. The new AMTPS composition was constituted by 25 wt% 
of the AMTPS top-phase, 20 wt% of Triton X-114, 0.3 wt% of IL and the appropriated 
amount of McIlvaine buffer at pH 6.0 in order to obtain the same concentration of the 
original AMTPS components, from where the top-phase was attained. A new consecutive 
cycle was also applied to the micelle-rich phase in an attempt to investigate the possibility 
of its reuse for a continuous IgY purification using a new WSPF. In this case, an 
appropriated amount (20.3 wt%) of the micelle-rich phase was added to a new WSPF in 
order to obtain the second AMTPS components in the same concentration prepared for 
the first one.  
2.2.4. Protein quantification of the micelle-poor phase by SE-HPLC analysis 
Proteins from both the WSPF and the micelle-poor phase of each AMTPS were quantified 
through size exclusion high performance liquid chromatography (SE-HPLC) with a size 
exclusion column Shodex Protein KW-802.5 (8 mm x 300 mm). Initially, the micelle-
poor phase was diluted (1:10) in 100 mM of phosphate buffer + NaCl at 0.3 M and pH 
7.0 (mobile phase), injected into the HPLC and run isocratically with a flow rate of 0.5 
mL.min-1 at 25ºC. The injection volume was 25µL and the wavelength was set at 280 nm 
using a diode array detector (DAD). The IgY quantification was carried out by an external 
standard calibration method in the range from 0.1 to 1.0 g/L. The chromatograms acquired 
from the HPLC were used for the determination of the IgY purity and recovery, which 
were estimated by Eqs 1 and 2, respectively: 
 
IgY purity (%) =
IgY area
(Contaminat Proteins+IgY) area
× 100                                                    (Eq. 1) 
  
 IgY yield (%) =
IgY weight𝑇𝑜𝑝 𝑝ℎ𝑎𝑠𝑒
IgY weight𝑖𝑛𝑖𝑡𝑖𝑎𝑙
× 100                                                                        (Eq. 2) 
  
where IgY weightTop phase represents: [IgY] in top phase × volume of top phase, and 
added IgY weightinitial corresponds to: [IgY] in WSPF × volume of WSPF added. Lastly, 
it should be noted that in the SE-HPLC analysis, due to the column sensitivity, it was not 
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always possible to use the same column for every system prepared. Therefore, and in 
order to minimize the effect of using a new column, a new calibration curve (depicted in 
Figure 1 of supporting information) was prepared for each column used. Furthermore, 
with the column usage the protein separation can be affected so, each set of results were 
prepared and analyzed at the same time in order to overcome those effects.  
 
2.2.5. SDS-PAGE analysis of both micelle-poor and micelle-rich phases 
Considering the impossibility to analyze the AMTPS micelle-rich phase through SE-
HPLC due to the surfactant and IL interference with the column and in order to analyze 
the micelle-rich phase, it was necessary to proceed to the use of sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) analysis. Thus, the SDS-PAGE analysis 
allowed the demonstration of the contaminants proteins presence in the micelle-rich phase 
through the determination of the proteins profile of both phases. In this context, three 
different methods were evaluated to precipitate the proteins and to allow the removal of 
all the surfactant and IL used in the AMTPS. The first methodology consisted in adding 
500 µL of acetone and 100 µL of a sample from each phase [86]. The second method 
comprised the addition of 200 µL of 20 % (w/v) of trichloroacetic acid (TCA) in acetone 
to 100 µL of a sample from each phase [87]. The third method involved 1000 µL of 
acetone/methanol (8:1) in 100 µL of a sample from each phase [86]. After the 
precipitation and the discard of the supernatant, the pellet was dissolved in 100 µL of the 
McIlvaine buffer. All samples were diluted in water so that the amount of protein in each 
lane was around 0.5 µg/mL. The samples were then diluted in a dissociation buffer 
consisting of 2.5 mL of 0.5 M Tris-HCl at pH 6.8, 4.0 mL of 10 % (w/v) of a SDS solution, 
2.0 mL of glycerol, 2.0 mg of bromophenol blue and 310 mg of dithiothreitol (DTT), 
followed by a 5 minutes incubation at 95ºC. This step allowed the protein denaturation 
and the disulfide linkage reduction, thus allowing the breakup of the protein quaternary 
structure when present in an unfolded state. The electrophoresis was carried out with a 
polyacrylamide gel (stacking and resolving gels at 4 and 20 %, respectively) from 
Amersham ECL Gel Box alongside with the running buffer (25 mM Tris, 192 mM glycine 
and 0.1% of SDS, pH 8.3), which was submitted to a pre-run during 12 minutes at 160 V. 
Afterwards, the samples and the full-range Amersham rainbow marker (12 to 225 kDa) 
were loaded into the gel and submitted to a run during 1.30 h at 135 V. Then, the gel was 
incubated overnight in an IKA KS 4000 ic control orbital shaker with 0.1 % (w/v), 50 % 
(v/v), 7 % (v/v) and 42.9 % (v/v) of Coomassie Brilliant Blue G-250, methanol, acetic 
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acid and water, respectively, in order to stain the proteins. The final step was the gel 
distaining with 7 % (v/v), 20 % (v/v) and 73 % (v/v) of acetic acid, methanol and water, 
respectively, in the same orbital shaker at 80 rpm during 3-6 hours at room temperature.   
 
2.2.6. IgY stability studies 
In order to study the effect of the surfactant as well as the IL (as co-surfactant) in the IgY 
stability, the best (conventional AMTPS with 20 wt % of Triton X-114 and the mixed 
AMTPS with 0.3 wt % of [C14mim]Cl) and worst (conventional AMTPS with 1 wt% of 
Triton X-114 and the mixed AMTPS with 0.3 wt% of [P8,8,8,8]Br) AMTPS towards the 
IgY purification, were analyzed by attenuated total reflection Fourier transform infrared 
spectroscopy (ATR- FT-IR) and SDS-PAGE. It should be stressed that in this step pure 
IgY was used, which was previously purified from an egg’s yolk by a Pierce Chicken IgY 
Purification Kit from Thermo Scientific. In both SDS-PAGE and FT-IR analysis only the 
top-phases were analyzed since the IgY, due to its hydrophilic nature, migrates 
preferentially towards the micelle-poor (top) layer. Owing to the interferences that protein 
concentration can display in a SDS-PAGE analysis and considering that AMTPS have 
the ability to concentrate the IgY, the control system in this case was prepared in the lower 
concentration that the antibody can be present in the top-phase. The FT-IR analysis were 
performed in a Perkin Elmer Spectrum Bx spectrophotometer and scanned between 
[2000-1000] cm-1 with a resolution of 4 cm−1 and 64 scans. These conditions were chosen 
since this is the most important interval when studying proteins owing to the localization 
of the amide I and II regions for the protein secondary structure determination [88]. 
Background (water vapour), McIlvaine buffer and each AMTPS blank spectra were also 
subtracted from all samples prior to data analysis in order to eliminate their interference 
from the samples containing pure IgY.  
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3. Results and Discussion 
3.1. IgY purification using the conventional and mixed AMTPS with ILs acting as 
co-surfactants  
Considering the aspects mentioned before, the main goal of this work is the development 
of a new IgY purification method using conventional and mixed AMTPS with ILs acting 
as co-surfactants. In this context, and considering that the biomolecules separation in 
these systems is dependent on surfactant concentration and temperature [30,70,71], the 
first step was the optimization of Triton X-114 and WSPF concentration on the IgY 
purification. Therefore, several conventional and mixed AMTPS in concentrations of 0.3 
and 0.5% of IL were prepared, since it has been reported that the addition of an IL into 
the AMTPS improved significantly the (bio)molecules selectivity [34]. Furthermore, 
different ILs families were carefully chosen in order to study the effect of tensioactive 
ILs’ structure, namely the imidazolium-based ILs that possess a more hydrophilic nature 
and the phosphonium-based ILs with a more hydrophobic character. 
As far as the surfactant concentration effect is concerned, the optimization study was 
evaluated using distinct conventional AMTPS composed of 1, 5, 10, 15 and 20 wt% of 
Triton X-114 for the IgY extraction and purification, being the results from the micelle-
poor phase displayed in Figures 5.A) and B).  
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Figure 5: A) Chromatograms for the AMTPS top phase at different surfactant concentrations upon phase 
separation at 35ºC:  ─, WSPF; ─, 1 wt% Triton X-114; ─, 5 wt% Triton X-114; ─, 10 wt% Triton X-114; 
─, 15 wt% Triton X-114; and ─, 20 wt% Triton X-114 and B) IgY purification (bars) and yield (line) in 
percentage (%), obtained for each AMTPS with different surfactant concentrations, (wt%) of Triton X-
114, upon phase separation at 35ºC. 
 
In the chromatogram depicted in Figure 5.A), it can be seen the presence of several peaks 
that correspond to IgY (15 minutes), main contaminant proteins (16, 17 minutes) and 
other small contaminants (27 and 37 minutes). At 23 minutes it is represented a peak 
associated with the residual presence of surfactant micelles. The analysis of both Figures 
5.A) and B) demonstrates that with the surfactant concentration increase, the IgY 
purification from the WSPF was improved from 34.6 to 44.3%, a profile accompanied by 
the complete recovery of the IgY into the micelle-poor (top) phase. This effect could be 
related with the fact that an increment in the surfactant concentration seems to increase 
the size of the micelles (i.e. with larger diameters and different shapes [68]), which 
resulted from the micelles fusion. Consequently, with the increase of the micelles 
diameter, the system has a greater capacity to concentrate a larger amount of contaminant 
proteins inside the micelles, which is more pronounced in the bottom phase. On the other 
hand, and due to the higher molecular weight of IgY, as well as its hydrophilicity, its 
entrance into the micelles is physically impossible, leading to their separation from the 
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main contaminant proteins. Both phenomenon, micelles size and hydrophilicity of IgY, 
are thus contributing to a higher IgY purification in the micelle-poor phase. Thereby, 
molecules with bigger sizes than the size of the micelles formed, will be located into the 
micelle-poor phase independently of the biomolecules hydrophobicity [25,27,66].  
As a second step of optimization, the WSPF concentration was studied on the IgY 
purification. In this context, several AMTPS composed of 10, 17.5 and 25 wt % of WSPF 
were performed. The chromatograms and the IgY purification and recovery are presented 
in Figures 6.A) and B), respectively. In this study, it was possible to verify that the 
increment in the WSPF concentration leads to an increase in the IgY purification since 
the amount of proteins added to the systems is also higher. These results can also suggest 
the possibly that the micelle-rich phase has not achieved saturation when a lower WSPF 
concentration was used. Additionally, it was possible to confirm that the systems do not 
present any IgY losses, as it can be seen in Figure 6.B). 
 
 
Figure 6: A) Chromatograms for the top phase of the AMTPS at different wt% of WSPF at pH 6 at 35ºC 
for ─, WSPF; ─,10 wt% WSPF; ─,17.5 wt% WSPF; and ─, 25 wt% WSPF and B) IgY purification (%) 
(bars) and yield (%) (lines), obtained for each system with different amounts of WSPF (wt%), and 20 
wt% of Triton X-114, upon phase separation at 35ºC. 
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Once the optimization study was finished, and aiming at designing a more efficient 
AMTPS for the purification of IgY, the mixed AMTPS were tested, namely those using 
ILs from the phosphonium and imidazolium families as co-surfactants, in order to study 
their potential in the enhancement of the biomolecules selectivity [34]. In this context, 
several modifications at the level of the alkyl side chain, the anion moiety and the cation 
core as well as the ILs’ concentration were studied. The alkyl side chain effect was 
evaluated through the imidazolium family, [Cnmim]Cl, by varying n between 10 and 18 
as presented by the chromatograms in Figure 7.A) and B), where it can be clearly seen a 
decrease in the protein contaminant peaks (16 and 17 minutes). This decrease is clearly 
demonstrated by the improvements of the IgY purification and yield as represented in 
Figure 7.C). Moreover, the anion influence was studied using the phosphonium family, 
through the cation [P6,6,6,14]
+ while using Cl-, Br-, Dec- and TMPP- as the anions 
conjugated. This family was also used to investigate the cations’ symmetry and the alkyl 
side chain by comparing [P6,6,6,14]Br with [P8,8,8,8]Br and [P6,6,6,14]Cl with [P4,4,4,14]Cl, 
respectively, since variations on the cation can be related to changes in viscosity, density 
and atom charge [89]. Thus, changes on the cation in the phosphonium family could be 
translated in different purification results as presented in Figures 8.A) and B) and Figure 
9.A) and B), respectively. It should be stressed that some of the chromatograms obtained 
in this study are displayed in Figure 2 of Supporting Information. Finally, the ILs 
concentration effect is visible over Figures 7, 8 and 9. 
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Figure 7: A) Chromatograms for the top-phase of the AMTPS with [Cnmim]Cl-based ILs at A) 0.3 wt% 
and B) 0.5 wt% at pH 6 for:  ─, WSPF; ─,  [C10mim]Cl ; ─, [C12mim]Cl; ─, [C14mim]Cl; ─, [C16mim]Cl; 
─, [C18mim]Cl. C) IgY purification (%) (bars) and yield (%)  (line) , obtained for each system with: ─, 
0.3 or ─, 0.5 wt% of the imidazolium-based ILs at the optimized system conditions ( 20 wt% of Triton X-
114 and 25 wt% of WSPF) at: , 35ºC;   ,37ºC; , 40ºC; and , 50ºC. 
 
Considering the results evidenced in Figures 7.A) and B), it is possible to verify that the 
best and worst imidazolium-based AMTPS for the IgY purification are the ones that use 
[C18mim]Cl and [C12mim]Cl, respectively, being both developed with 0.5 wt% of IL. The 
achieved results can be explained by the formation of mixed micelles, since the addition 
of IL as co-surfactants seems to lead to the incorporation of some IL monomers alongside 
the Triton X-114 monomers, thus driving the system to exhibit mixed micelles with 
different diameters and shapes as well as superficial charges [81–84]. However, it is 
important to notice that the results for the imidazolium-based ILs were not studied at the 
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same temperature due to their Tcloud variation, i.e. when the alkyl side chain of the IL 
increases, so does the system hydrophobicity and thus, lowering the temperature required 
to promote the phase separation [34]. Therefore, when comparing these results, it was 
mandatory to have this fact into attention since the AMTPS phase separation is 
temperature dependent [67]. In this sense, it was impossible to exhibit the data for 0.5 
wt% of [C10mim]Cl owing to the absence of a phase separation until 50ºC. It is also 
important to note that alterations on temperature can also lead to changes in the CMC 
since as the temperature increases, the hydration shell of the imidazolium heads 
decreases, leading to an increased hydrophobicity [79,80]. This hydrophobicity increment 
can affect the phase separation, phase volume (data not shown) as well as the purification 
results. In this case, it seems that a temperature increment leads to a decrease in the IgY 
purification (Figure 7). However, the IgY loss should not associated to the temperature 
increase since this antibody is stable until 70ºC [39].  Furthermore, and according to the 
results from the IgY yield, it can be seen that the best results are attained for the highest 
temperatures tested, as 100% of IgY yield was obtained with [C10mim]Cl.  
Additionally, and taking into consideration the results for [C16mim]Cl and [C18mim]Cl 
obtained in the same temperature (Figure 7), it was possible to conclude that when the 
IL’s alkyl side chain increased, a better extraction of the contaminants proteins was 
obtained for the opposite phase of IgY, resulting in the higher antibody purity that is 
present in the micelle-poor phase. This effect is even more pronounced when the IL 
concentration increases from 0.3 to 0.5 wt%. Moreover, the increment of the IL’s alkyl 
side chain can lead to an increase in the IL hydrophobicity, which in turn tends to create 
problems in its dissolution in the surfactant and buffer and also contributes to a decrease 
in the CMC values [78]. In summary, it is possible to state that the addition of the 
imidazolium-based ILs as co-surfactant to the AMTPS can improve the IgY purification 
from 51.2 % to 68.9 %.  
Afterwards and as aforementioned, several studies were carried out incorporating the 
phosphonium based-ILs in the AMTPS for the extraction and purification of IgY and its 
results can be seen over Figures 8.A and B) and 9.A) and B).  
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Figure 8: Chromatograms for the AMTPS top-phase at (A) 35ºC and (B) 37ºC with phosphonium-based 
ILs at 0.3 wt% and pH 6 for: ─, WSPF; ─ , [P6,6,6,14]Cl; ─, [P6,6,6,14]TMMP; ─, [P6,6,6,14]Br; ─, 
[P6,6,6,14]Dec; ─,  [P8,8,8,8]Br; ─,  [P4,4,4,14]Cl.
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Figure 9: IgY purification (bars) and yield (line) in percentage (%) obtained for each system with  ─, 0.3 and ─, 0.5 wt% of phosphonium-based IL at , 35ºC and , 37ºC 
for the same system with 20 wt% of Triton X-114 and 25 wt% of WSPF. 
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According to Figure 9, the addition of phosphonium-based ILs to the AMTPS reduces 
the IgY purification (results depicted as bars) in comparison with the results obtained for 
the conventional system. This effect could be related with the more hydrophobic nature 
of the IL, which can impose difficulties to the extraction of the hydrophilic contaminant 
proteins, even though these ILs have shown a better phase separation [90] (data not 
showed). Furthermore, through the results attained for the longer phosphonium-based 
ILs, [P6,6,6,14]
+,  at both concentrations (0.3 and 0.5 wt%), it was possible to verify that the 
anion effect does not seem to be significant for the purification of IgY and neither it is for 
the IL concentration. When the cation effect was concerned, the achieved results at 37ºC 
showed that the IgY purification followed the increasing tendency: [P4,4,4,14]
+  > [P6,6,6,14]
+ 
>[P8,8,8,8]
+, whereas the IgY yield presented a decreasing trend: [P6,6,6,14]
+ < [P8,8,8,8]
+ < 
[P4,4,4,14]
+. Through the phosphonium family, it was proven once again that the 
temperature increase leads to a decrease in the IgY purification as well as a variation of 
the phase separation and phase volume (data not showed) as it was predicted from 
literature [67]. Considering these results, it was possible to conclude that the 
phosphonium-based ILs are less effective for the IgY extraction and purification when 
compared with imidazolium-based ILs, possibly due to hydrophilic/hydrophobicity 
differences. 
3.1.1. SDS-PAGE analysis of micelle-poor and -rich phases for conventional and mixed 
AMTPS  
In view of the impossibility to analyze the AMTPS micelle-rich phase through SE-HPLC 
and in order to investigate the AMTPS capacity to extract the contaminant proteins in the 
micelle-rich phase, it was necessary to proceed to the use of SDS-PAGE analysis. 
However, since the surfactant (Triton X-114) and co-surfactant (IL) can interfere with the 
gel running, it was indispensable the proteins precipitation in both AMTPS phases. For 
this purpose, three different precipitations methods were tested, acetone, acetone/TCA 
and acetone/methanol being the results presented in Figure 10.  
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Figure 10: SDS-PAGE gel of the supernatant after different protein precipitation methods used in both 
micelle-poor and micelle-rich phases for the conventional AMTPS with 20 wt% of Triton X-114.  
From the gel analysis, it is easily seen that the method showing better results was the one 
using acetone/methanol (8:1), exhibiting more defined bands for both IgY heavy (65-68 
kDa) and IgY light (25 kDa) chains, as well as the contaminants. Furthermore, in the 
micelle-poor phase, it is not possible to distinguish the bands between the IgY heavy 
chain band and the contaminant proteins. Bearing in mind these results, the 
acetone/methanol precipitation method was also applied to the systems with IL as an 
approach to verify the IgY and the contaminant proteins migration during the purification 
tests (Figure 11).  
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Figure 11: SDS-PAGE gel of the resulting from the protein precipitations both micelle-poor and micelle-rich phase of conventional AMTPS with 20 wt% of Triton X-114 
and mixed AMTPS with 0.3 wt% IL acting as co-surfactant.  
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Considering the polyacrylamide gel presented in Figure 11, it is verified that for the 
conventional AMTPS there is some contaminant proteins in the micelle-rich phase, but 
this extraction was not complete since, in the micelle-poor phase, there are still some 
bands corresponding to contaminant proteins. From the observation of the lane 
corresponding to the micelle-poor phase of the conventional AMTPS, it can also be noted 
the presence of the IgY heavy chain band (65-68 kDa) and the IgY light chain band (25 
kDa), however, these bands are not visible in the micelle-rich phase of the conventional 
AMTPS. Therefore, it can be stated that IgY was completely extracted for the micelle-
poor phase as it was expected according to the yield results of 100% as previously shown. 
The same behavior can be observed for the mixed AMTPS with 0.3 wt% of IL at 37ºC: 
[P6,6,6,14]TMPP, [P6,6,6,14]Cl, [P6,6,6,14]Dec, [P6,6,6,14]Br and [P8,8,8,8]Br. Focusing on the 
particular cases of [P4,4,4,14]Cl and [C14mim]Cl, it can be recognized that these systems 
can indeed extract a higher number of contaminant proteins. Furthermore, it was also 
possible to confirm that [P4,4,4,14]Cl is one of the best phosphonium-based ILs for the 
purification of IgY and that [C14mim]Cl is the overall system that presents a better IgY 
purification.  
3.2. Consecutive extraction cycles using mixed AMTPS for the IgY extraction and 
purification  
After considering the results achieved in the extraction and purification of IgY using 
mixed AMTPS, extraction cycles were applied to the top-phases from the mixed AMTPS 
that exhibited better purification and yield results aiming to improve the purification of 
IgY as already reported to other compounds [91]. The AMTPS chosen was the one 
presenting better results during the ILs screening, corresponding to 0.3 wt% of 
[C14mim]Cl. This choice was made taking into account both the IgY purification and yield 
in order to attain the maximum purity and yield of IgY, being these results presented in 
Figures 12.A) and B). 
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Figure 12: A) Chromatograms for the top-phase form the extraction cycles with 0.3 wt% of [C14mim]Cl 
at pH 6 and 37ºC for: ─, WSPF; ─ 1st extraction cycle; *, 2nd  extraction cycle; ─ ─, 3rd  extraction cycle 
and B) IgY purification (%) (bars) and yield (%) (line) obtained for each extraction cycle with 0.3 wt% of 
[C14mim]Cl, upon phase separation at 37ºC. 
When analyzing Figure 12, it was possible to observe that the addition of new extraction 
cycles improved the purification of IgY. However, these improvements come with 
significant IgY losses. Moreover, by comparing the second and third cycles, the second 
one seems to exhibit a higher efficiency since, in this case, the IgY is more purified than 
the one obtained for the third cycle besides the fact that IgY losses are much lower. When 
proceeding to the use of extraction cycles towards the purification of IgY, the same 
problem regarding the analysis of the micelle-rich phase was faced. Therefore, it became 
necessary once again the use of SDS-PAGE for its analysis. The results are shown in 
Figure 13. 
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Figure 13: SDS-PAGE gel of the resulting from the protein precipitation of the micelle-poor and micelle-
rich phase of the different extraction cycles using 0.3 wt% of [C14mim]Cl.  
 
According to the SDS-PAGE depicted in Figure 13, it is concluded that the new 
extraction cycles are able to extract the contaminant proteins from the WSPF. However, 
the presence of IgY bands was also observed in the micelle-rich phase of each cycle, 
which was in accordance with the decreasing values of IgY yield in each new AMTPS. 
In conclusion, this analysis confirms that the addition of new extraction cycles has the 
capacity of purify and concentrate the IgY, though the total extraction of contaminants is 
not achieved.  
3.3. Consecutive extraction cycles for reuse of micelle-rich phase  
Afterwards, the micelle-rich phase was studied considering its potential saturation, and in 
this sense, the bottom phase was reused for a second cycle of extraction with a new WSPF 
(Figure 14). 
41 
 
 
Figure 14: A) Chromatograms for the top-phase form the extraction cycles with 20 wt% of Triton X-114 
and 0.3 wt% of [C14mim]Cl at pH 6 and 37ºC for: ─, WSPF; ─, 1st   extraction cycle and *, 2nd  extraction 
cycle and B) IgY purification (%) (bars) and yield (%) (line) obtained for the new extraction cycle with 
0.3 wt% of [C14mim]Cl with micelle-rich phase reutilization, upon phase separation at 37ºC. 
In Figure 14.A) and B), it can be seen that the purification of IgY decreased when the 
micelle-rich phase was reused. Therefore, this study indicates that the micelle-rich phase 
seems to be saturated, which was translated in its inability to extract more contaminant 
proteins in presence of a new WSPF.  
3.4. IgY stability studies 
As a way to validate the results acquired for the extraction and purification of IgY, 
stability studies were conducted to determine if the AMTPS interfere with the molecular 
structure of IgY. Thus, new conventional AMTPS and mixed AMTPS were prepared with 
pure IgY in order to assure that any variations in the molecular structure were only 
associated with the antibody and not with the contaminants. The achieved micelle-poor 
phases were then analyzed by SDS-PAGE and FI-TR and the antibody stability was 
evaluated, being its results presented in Figures 15 and 16.  
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Figure 15: SDS-PAGE gel of some conventional and mixed AMTPS micelle-poor phases with pure IgY 
at distinct surfactant concentrations; stained with Coomassie G-250. 
 
Figure 16: Infrared spectra of pure IgY in conventional and mixed AMTPS. (a) Pure IgY; (b) IgY in 
AMTPS below the CMC; (c) Pure IgY in AMTPS in the CMC; (d) Pure IgY in AMTPS with 1 wt% of 
Triton X-114; (e) Pure IgY in 20 wt% of Triton X-114; (f) Pure IgY in AMTPS with 0.3 wt% of 
[C14mim]Cl; (g) Pure IgY in AMTPS with 0.3 wt% of [P8,8,8,8]Br. 
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From the results presented in Figure 15, it is possible to detect that the band 
corresponding to the IgY heavy chain (65-68 kDa) only suffers a slight alteration for the 
AMTPS with 0.3 wt% of [P8,8,8,8]Br, which could indicate some change on the antibody 
molecular structure. There are also changes in the band intensity corresponding to 
concentration variations, which can be explained by the  ability of these specific AMTPS 
to concentrate this antibody [66]. The next step was the analysis of the same top-phases 
through FT-IR, (Figure 16). From the FT-IR spectra of IgY, two different regions were 
identified as important for the structural integrity analysis of the secondary structure: i) 
the amide I, which corresponds to stretching vibration of the group C=O, and ii) the amide 
II that corresponds to stretching on C=N group. Variations on this region can be attributed 
to β-sheet structures (≈1635 cm-1), as well as α-helices (≈1660 cm-1), random coil (≈1645 
cm-1) and β-turn (≈1670 cm-1). These regions are usually used to identify several elements 
from secondary structures of proteins [88]. Considering these amide I and II regions, it 
can be seen some peak variations for the systems below the CMC (b), with 1 wt% of 
Triton X-114 (d), and with 20 wt% of Triton X-114 and 0.3 wt% of [P8,8,8,8]Br (g), when 
compared to the pure IgY in the McIlvaine buffer. These results could be translated in 
possible changes in the molecular structure of the IgY. When analyzing the AMTPS 
corresponding to very low amounts of surfactant, for instance the systems below the CMC 
(b) and at the CMC (c), some alterations on the amide region were also detected. These 
results could be associated with surfactant interferences in the IgY molecular structure 
since the systems do not present surfactant micelles formation for the case below the 
CMC. Overall, these results indicate that, the systems that present more alterations in the 
amide I and II regions, are the same that exhibit worst purification results: the 
conventional AMTPS with 1 wt% of surfactant and the mixed AMTPS with 0.3 wt% 
[P8,8,8,8]Br.  
Lastly, it should be stressed that, even though SE-HPLC analysis is more widely used for 
quantification proposes, it can also be used to investigate the formation of aggregates as 
well as protein denaturation [92]. In this sense, taking into consideration the findings 
discussed throughout this work and the absence of any new peaks, it can be corroborated 
that these systems do not seem to cause the biomolecules denaturation and/or aggregation.     
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3.5. Conventional vs novel methods for antibodies extraction and purification  
Over the years, a considerable number of methods have been applied in the purification 
of IgY as well as IgG, as presented in Table 2.  These methods are usually coupled with 
other techniques in order to improve the purification of the antibody. However, in this 
work, it is presented for the first time the use of conventional and mixed AMTPS for the 
purification of IgY from WSPF originated from hens’ egg yolk in a single step 
purification. Nevertheless, in this study, the achieved purification levels are dependent on 
the AMTPS applied and the number of extraction cycles. The purity values ranged 
between 51.2 % with a yield of 100% for conventional AMTPS and 64.5% with 74.7% 
of yield when mixed AMTPS are used. Moreover, the purification results can be improved 
when consecutive extraction cycles are imposed, reaching purity values of 73.4%. 
Overall, the application of AMTPS for IgY purification seems to be more advantageous 
when compared with literature (Table 2) because, even though the results can be slightly 
inferior to the ones reported, the use of AMTPS allows the purification of IgY without 
requiring the addition of another technique, specially an expensive one. Additionally, 
AMTPS avoids the use of organic solvents usually applied in conventional liquid-liquid 
extraction methods, making this method more environmental friendly and biocompatible.   
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Table 2: Comparison of different methods for antibody extraction and purification. 
Antibody Method Purification Yield 
IgG From colostral whey with reverse micelles [93] 90% 90% 
IgY 
 
With water solution, salt precipitation and gel 
chromatography [94] 
99% - 
Membrane based two-stage ultrafiltration 
process [85] 
93% 87% 
Natural gums (λ-carrageenan) and isolation of 
IgY by chromatography [40] 
98% 86% 
Single step chromatography with affinity 
columns with TG19318 ligand [16] 
90% - 
Lipids removal, followed by different 
precipitation methods [15] 
The best methods had 
purifications of 60% 
- 
Antibody partitioning using PEG 
1500/potassium phosphate [41] 
With a IgY yield of 9mg/ml of egg yolk 
Ultrafiltration with several membranes with 
different cut-offs [17] 
74-99% 72-85% 
Preparative electrophoresis [95] - 80% 
Conventional AMTPS  51.2% 100% 
Mixed AMTPS with ILs as co-surfactant 68.9% 30.6% 
Consecutive extraction cycles with mixed 
AMTPS 
73.4% 4.7% 
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4. Final Remarks 
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4. Final remarks  
4.1. General conclusions and future work 
In this work, the use of AMPTS is reported for the first time regarding the purification of 
IgY from the WSPF from hens’ egg yolk. The application of these systems allowed an 
improvement of the IgY purification from 34.6% to 51.2%. in the case of conventional 
AMTPS. Furthermore, the use of mixed AMTPS with imidazolium-based IL as co-
surfactants showed an enhanced capacity to increase even more the purification results 
up to 68.9% with [C18mim]Cl. Moreover, these systems seem to be a biocompatible 
alternative since the IgY molecular stability does not suffer any significant alterations 
upon phase separation.  
In summary, AMTPS seem to be a viable method to IgY purification; however, further 
research should be made in order to evaluate the antibody activity as well as its recovery 
from the top-phase. In this sense, dialysis could be a good method to recover IgY in 
phosphate saline buffer (PBS) instead of the top-phase that could still exhibit some 
micelles even though in a very low concentration. Furthermore, considering the amounts 
of surfactant used here and as a way to avoid any environmental impact, the recovery and 
reuse of the surfactant and IL should be attempted, so the costs of IgY purification could 
be minimized. In this case, micellar-enhanced ultrafiltration (MEUF) [96] or a foam 
separation process [97] could be used in order to remove surfactant micelles. 
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6. Supporting Information 
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Figure 1:  SE-HPLC pure IgY control A) and calibration curve B) for the total IgY concentration at 
λ=280nm.  
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Figure 2: Chromatograms for the top-phase of the AMTPS at a) 35ºC and b) 37ºC with phosphonium-
based ILs at 0.5 wt% and pH 6 for: ─, WSPF; ─ , [P6,6,6,14]Cl; ─, [P6,6,6,14]TMMP; ─, [P6,6,6,14]Br; ─, 
[P6,6,6,14]Dec; ─,  [P8,8,8,8]Br; ─,  [P4,4,4,14]Cl.
 
